Notably, STL001 does not exert prominent cytotoxic effects on its own; however, it sensitizes cancer cells to a broad spectrum of conventional chemotherapeutic drugs most probably by increasing the vulnerability of cancer cells via suppressing the activity of FOXM1 and its downstream pathways involved in cancer survival and drug resistance. This evidence concerns the gene FOXM1 and cancer.